Cite
One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
MLA
Mancini, Francesca, et al. “One Dose of Staphylococcus Aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.” PLoS ONE, vol. 11, no. 1, Jan. 2016, pp. 1–18. EBSCOhost, https://doi.org/10.1371/journal.pone.0147767.
APA
Mancini, F., Monaci, E., Lofano, G., Torre, A., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Galletti, B., Laera, D., Pallaoro, M., Tuscano, G., Fontana, M. R., Bensi, G., Grandi, G., Rossi-Paccani, S., Nuti, S., Rappuoli, R., De Gregorio, E., & Bagnoli, F. (2016). One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A. PLoS ONE, 11(1), 1–18. https://doi.org/10.1371/journal.pone.0147767
Chicago
Mancini, Francesca, Elisabetta Monaci, Giuseppe Lofano, Antonina Torre, Marta Bacconi, Simona Tavarini, Chiara Sammicheli, et al. 2016. “One Dose of Staphylococcus Aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.” PLoS ONE 11 (1): 1–18. doi:10.1371/journal.pone.0147767.